223 related articles for article (PubMed ID: 24379638)
1. Efficacy of mosapride plus proton pump inhibitors for treatment of gastroesophageal reflux disease: a systematic review.
Liu Q; Feng CC; Wang EM; Yan XJ; Chen SL
World J Gastroenterol; 2013 Dec; 19(47):9111-8. PubMed ID: 24379638
[TBL] [Abstract][Full Text] [Related]
2. Randomized controlled trial comparing the efficacy of mosapride plus omeprazole combination therapy to omeprazole monotherapy in gastroesophageal reflux disease.
Yamaji Y; Isomura Y; Yoshida S; Yamada A; Hirata Y; Koike K
J Dig Dis; 2014 Sep; 15(9):469-76. PubMed ID: 24957863
[TBL] [Abstract][Full Text] [Related]
3. Effect of mosapride combined with esomeprazole improves esophageal peristaltic function in patients with gastroesophageal reflux disease: a study using high resolution manometry.
Cho YK; Choi MG; Park EY; Lim CH; Kim JS; Park JM; Lee IS; Kim SW; Choi KY
Dig Dis Sci; 2013 Apr; 58(4):1035-41. PubMed ID: 23053900
[TBL] [Abstract][Full Text] [Related]
4. The prokinetic effect of mosapride citrate combined with omeprazole therapy improves clinical symptoms and gastric emptying in PPI-resistant NERD patients with delayed gastric emptying.
Futagami S; Iwakiri K; Shindo T; Kawagoe T; Horie A; Shimpuku M; Tanaka Y; Kawami N; Gudis K; Sakamoto C
J Gastroenterol; 2010 Apr; 45(4):413-21. PubMed ID: 19997942
[TBL] [Abstract][Full Text] [Related]
5. The treatment efficacy of adding prokinetics to PPIs for gastroesophageal reflux disease: a meta-analysis.
Xi L; Zhu J; Zhang H; Muktiali M; Li Y; Wu A
Esophagus; 2021 Jan; 18(1):144-151. PubMed ID: 32519226
[TBL] [Abstract][Full Text] [Related]
6. Addition of prokinetics to PPI therapy in gastroesophageal reflux disease: a meta-analysis.
Ren LH; Chen WX; Qian LJ; Li S; Gu M; Shi RH
World J Gastroenterol; 2014 Mar; 20(9):2412-9. PubMed ID: 24605040
[TBL] [Abstract][Full Text] [Related]
7. Additional Mosapride to Proton Pump Inhibitor for Gastroesophageal Reflux Disease: A Meta-Analysis.
Nishizawa T; Mori K; Yoshida S; Ebinuma H; Toyoshima O; Suzuki H
J Clin Med; 2020 Aug; 9(9):. PubMed ID: 32825721
[TBL] [Abstract][Full Text] [Related]
8. [A comparative study of therapy effects between esomeprazole plus mosapride citrate and botulinum toxin injection on vocal process granuloma].
Lei L; Yang H; Zhao Y; Zhang XS; Zou J; Ren J; Zheng YT; Ren JJ
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jul; 31(13):1006-1009. PubMed ID: 29798164
[No Abstract] [Full Text] [Related]
9. Mosapride as an adjunct to lansoprazole for symptom relief of reflux oesophagitis.
Hsu YC; Yang TH; Hsu WL; Wu HT; Cheng YC; Chiang MF; Wang CS; Lin HJ
Br J Clin Pharmacol; 2010 Aug; 70(2):171-9. PubMed ID: 20653670
[TBL] [Abstract][Full Text] [Related]
10. Effects of the Addition of Mosapride to Gastroesophageal Reflux Disease Patients on Proton Pump Inhibitor: A Prospective Randomized, Double-blind Study.
Lim HC; Kim JH; Youn YH; Lee EH; Lee BK; Park H
J Neurogastroenterol Motil; 2013 Oct; 19(4):495-502. PubMed ID: 24199010
[TBL] [Abstract][Full Text] [Related]
11. The effect of mosapride, a novel prokinetic, on acid reflux variables in patients with gastro-oesophageal reflux disease.
Ruth M; Hamelin B; Röhss K; Lundell L
Aliment Pharmacol Ther; 1998 Jan; 12(1):35-40. PubMed ID: 9692698
[TBL] [Abstract][Full Text] [Related]
12. Addition of prokinetic therapy to a PPI in reflux diseases.
Hsu YC; Lin HJ
Aliment Pharmacol Ther; 2011 Apr; 33(8):983-4; author reply 984-5. PubMed ID: 21434953
[No Abstract] [Full Text] [Related]
13. Comparison of the effects of esomeprazole plus mosapride citrate and botulinum toxin A on vocal process granuloma.
Lei L; Yang H; Zhang X; Ren J
Am J Otolaryngol; 2017; 38(5):593-597. PubMed ID: 28655420
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of the four weeks treatment of omeprazole plus mosapride combination therapy compared with that of omeprazole monotherapy in patients with proton pump inhibitor-refractory gastroesophageal reflux disease: a randomized controlled trial.
Sirinawasatien A; Kantathavorn N
Clin Exp Gastroenterol; 2019; 12():337-347. PubMed ID: 31440072
[TBL] [Abstract][Full Text] [Related]
15. A review of medical therapy for proton pump inhibitor nonresponsive gastroesophageal reflux disease.
Hillman L; Yadlapati R; Thuluvath AJ; Berendsen MA; Pandolfino JE
Dis Esophagus; 2017 Sep; 30(9):1-15. PubMed ID: 28859358
[TBL] [Abstract][Full Text] [Related]
16. Treatment of PPI-resistant gastro-oesophageal reflux: A systematic review.
Gallusi G; Pontone S
Arab J Gastroenterol; 2018 Jun; 19(2):51-55. PubMed ID: 29935866
[TBL] [Abstract][Full Text] [Related]
17. Mosapride (5HT4 agonist) in the treatment of blepharospasm.
Piyasena IN; Jayasinghe JA
Ceylon Med J; 2014 Mar; 59(1):26-7. PubMed ID: 24682196
[No Abstract] [Full Text] [Related]
18. Mosapride for gastroesophageal reflux disease in neurologically impaired patients.
Komura M; Kanamori Y; Tanaka Y; Kodaka T; Sugiyama M; Terawaki K; Suzuki K; Iwanaka T
Pediatr Int; 2017 Mar; 59(3):347-351. PubMed ID: 27561215
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of acotiamide in combination with esomeprazole for functional dyspepsia refractory to proton-pump inhibitor monotherapy.
Mayanagi S; Kishino M; Kitagawa Y; Sunamura M
Tohoku J Exp Med; 2014 Nov; 234(3):237-40. PubMed ID: 25382232
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omeprazole-controlled randomized study (J-FOCUS).
Sakurai K; Nagahara A; Inoue K; Akiyama J; Mabe K; Suzuki J; Habu Y; Araki A; Suzuki T; Satoh K; Nagami H; Harada R; Tano N; Kusaka M; Fujioka Y; Fujimura T; Shigeto N; Oumi T; Miwa J; Miwa H; Fujimoto K; Kinoshita Y; Haruma K
BMC Gastroenterol; 2012 May; 12():42. PubMed ID: 22548767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
